Why do you say that many "unicorns" will be born in the field of precision medicine?
The investment in the medical and health industry has long been concerned by investors. The data shows that in the first half of 2016, there were 122 private equity investments in the industry, and the number of investment cases ranked third in all industries, with a total investment of 17.2 billion yuan, ranking sixth in all industries. It can be seen from some famous investment cases in the first half of the year that social capital such as Shanxi Merchants Union and Ali Department began to deeply intervene in the investment of the medical industry . At the same time, domestic enterprises such as Fosun Pharma and Renfu Medicine also increased the pace of overseas mergers and acquisitions. Accelerate its layout in the segmented industry through overseas mergers and acquisitions. Song Huaien, a partner of Shengshi Investment, believes that the fields of precision medicine and biosimilars are promising.
Great potential for precision medicine
With the development of modern biomedical technology, precision medicine has received more and more attention. In 2015, the Ministry of Science and Technology held the “National Precision Medical Strategy Expert Meetingâ€, which plans to invest 60 billion yuan into the precision medical field by 2030. On June 25 this year, the National Science and Technology Management Information System Public Service Platform issued the "Notice on Publicizing the 2016 Project Arrangement of the National Key Research and Development Program "Precise Medical Research"", clearly indicating that the "precise medical research" key project will be The 2016 project information that entered the review process was publicized, and a total of 61 projects entered the publicity list. The central government financial support amounted to 640 million yuan. This is the beginning of the project in the field of precision medical research after the establishment of the precision medical plan in China.
The future of the precision medical market is huge, but it depends on the further development and improvement of related fields. Song Huaien pointed out that precision medicine is actually an individualized treatment, which is to give patients individualized treatment through accurate diagnosis, which makes the treatment more precise, and reduces the harm caused to the patient by blind use of drugs and reduces medical expenses. In many studies of hereditary diseases, scientists have a relatively deep understanding of what diseases a mutation can cause. For example, the genetic diagnosis of Baylor College of Medicine in the United States has been done in depth, and can do 4000 genetic testing projects. Diagnosis of clinically relevant genetic diseases by clinicians. However, now we still need to make breakthroughs in various fields such as protein biochemistry and genomics, clearly know which genes cause diseases, and then treat diseases by genetic modification and other means without changing other normal genes in the body. Or prevent it in advance, without side effects. Precision medicine needs to increase technology research and development and technology investment. The future imagination of this field is very large, or many high-tech companies with "unicorn" type will be born. Early deployment of precision medicine is crucial to building a new driving force for the development of China's life and health industry.
Anti-tumor drug therapy represented by targeted drugs is currently a relatively mature field of precision medicine. In recent years, global cancer mortality has topped the list. According to IMS data, global cancer treatment and maintenance treatments cost up to $107 billion last year. As the incidence of cancer continues to rise, the future demand for oncology drugs is huge. According to statistics, 20 of the world's best-selling 100 drugs in 2015 were cancer treatment drugs, with sales of 520 US dollars, accounting for 20% of the largest market share.
According to Song Huaien, at present, the latest development of a variety of new tumor immunotherapy drugs abroad is one of the important directions for future cancer treatment. "In the course of clinical cancer treatment, traditional chemotherapy, radiotherapy or prolong life, but can not solve the most fundamental problems, some experts have developed cellular immunotherapy, can directly kill cancer cells, control tumor development and metastasis, and even reverse tumor cells In general, the field of cancer immunotherapy is relatively new, and development still requires huge investment, and there are also many risks and challenges."
We're professional Medical Accessory Device manufacturers and suppliers in China, specialized in providing high quality medical instruments with reasonable price. We warmly welcome you to buy or wholesale bulk Medical Accessory Device for sale here and get quotation from our factory.
Medical Accessory Device,Medical Device Accessory,Rigid Containers For Sterilization,Surgical Instrument Containers
Tonglu WANHE Medical Instrument Co., Ltd , https://www.vanhurhealth.com